SEC-sourced researchBeta
CELU
Celularity Inc
Company comparison ↗
Data passport
- CIK
- 0001752828
- Exchange
- Nasdaq
- Business activity
- Pharmaceutical Preparations · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 54,220,000.0000 | Apr 30, 2026 |
| December 2025 | 26,550,000.0000 | Apr 30, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 26,550,000.0000 | -91,716,000.0000 | -13,254,000.0000 | 107,329,000.0000 | 145,391,000.0000 | Apr 30, 2026 |
| December 2024 | 54,220,000.0000 | -57,892,000.0000 | -6,401,000.0000 | 132,682,000.0000 | 123,845,000.0000 | Apr 30, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
20/100
Profitability0
Growth0
Balance sheet0
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $26.55M | Jan 1, 2025 – Dec 31, 2025 | Apr 30, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $54.22M | Jan 1, 2024 – Dec 31, 2024 | Apr 30, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$91.72M | Jan 1, 2025 – Dec 31, 2025 | Apr 30, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$13.25M | Jan 1, 2025 – Dec 31, 2025 | Apr 30, 2026 | 10-K |
| Total assetsAssets | $107.33M | Dec 31, 2025 | Apr 30, 2026 | 10-K |
| Total liabilitiesLiabilities | $145.39M | Dec 31, 2025 | Apr 30, 2026 | 10-K |
New filings
- NT 10-QCELU · Celularity IncNov 16, 2026 · Other
- ARSCELU · Celularity IncNov 10, 2026 · Other
- DEFA14ACELU · Celularity IncNov 10, 2026 · Other
- DEF 14ACELU · Celularity IncNov 10, 2026 · Other
- 8-KCELU · Celularity IncOct 29, 2026 · Current event
- PRE 14ACELU · Celularity IncOct 29, 2026 · Other
- 10-QCELU · Celularity IncOct 20, 2026 · Periodic
- 10-K/ACELU · Celularity IncOct 20, 2026 · Annual
- 8-KCELU · Celularity IncSep 29, 2026 · Current event
- 10-QCELU · Celularity IncSep 29, 2026 · Periodic
- 8-KCELU · Celularity IncSep 28, 2026 · Current event
- SCHEDULE 13D/ACELU · Celularity IncSep 28, 2026 · Other
- 4CELU · Celularity IncSep 25, 2026 · Other
- 4CELU · Celularity IncSep 25, 2026 · Other
- 4CELU · Celularity IncSep 25, 2026 · Other